Establishment the method of surveillance to find early pancreatic cancer for high risk individuals with familial Pancreatic Cancer or hereditary neoplastic syndrome
Not Applicable
Recruiting
- Conditions
- pancreatic cancer
- Registration Number
- JPRN-UMIN000039779
- Lead Sponsor
- ational Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
total gastrectomy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method the population of resecatble pancreatic cancer of pancreatic cancer
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie early detection of familial pancreatic cancer in the DIAMOND study?
How does the DIAMOND study compare with standard surveillance methods for hereditary neoplastic syndrome-associated pancreatic cancer?
Which biomarkers are being evaluated for patient selection in JPRN-UMIN000039779 to identify early-stage pancreatic cancer?
What adverse events are associated with surveillance protocols in high-risk pancreatic cancer populations?
Are there combination approaches or competitor strategies for early detection of pancreatic cancer in hereditary syndromes?